sales flat in first quarter, pfizer lowers forecast for the year
rivals are selling generic versions of the company's older drugs, and analysts wonder about spinning off some units.
http://feeds.nytimes.com/click.phdo?i=6ee4fbd925c5e566f443f93ef94e835e
15009
04 May 2011 07:25:14
nyt
business